Véronique Rebours-Mory


As CEO of Esperante Development, our goals are focussed on research and development for new technologies and treatments to improve patient outcomes.

My 30 + years’ career has consisted of successful management of Scientific Corporate Departments and Affiliates in the pharmaceutical industry within an international and multicultural environment.

By way of training, I have a PharmD from the University Claude Bernard in Lyon France.

During my career in the pharmaceutical industry I have held a variety of roles that have allow me to have a broad view of the pharma industry activities while also progressed from Pharma Sales Representative, to Clinical Study Manager, Business Development Manager /Director, Managing Director, Senior VP, CSO at Sever Life Sciences (SLS) and CEO of Esperante Development

My CSO role covers, Scientific Affairs with a focus on Innovation, Product Development and Business Development (licensing & acquisition). My responsibilities in these areas are mainly concerned with the guidance of company projects and managing resources to support departmental delivery.

As CEO of the SLS affiliate, Esperante Development, our goals are focused on Innovation and Development to expand SLS companies’ portfolio with treatments that will improve diseases’ management and patient outcomes. We are currently expanding our skills and know-how in sterile products (injectable and ophthalmic).

Back to Company Profile
Visit Esperante Development